Dean Slagel

Non-Executive Director at Arquer Diagnostics

Dean represents Esperante Ventures, a significant investor in Arquer. He has an MBA from ENPC Business School, Paris. Following 10 years with the Ferring Pharmaceuticals group in global operations and business development management, he has led Esperante Ventures since 2004, building and growing an investment portfolio of pharmaceutical and diagnostics companies in North America, Europe, and Israel with 4 successful exits to date.

Org chart

Alex Buchan

Director

David Denny

Non-Executive Director

Nick Miller-Jones

Founder & Non-Executive Director

William P. Moffitt

Chairman

Timeline

  • Non-Executive Director

    Current role